Home / Publications / Pain Research Forum / Papers of the Week / Face validity of the ICD-10 criteria of substance abuse and dependence for patients prescribed cannabis-based medicines for chronic pain – a survey of pain medicine physicians in Canada, Germany and Israel.
Face validity of the ICD-10 criteria of substance abuse and dependence for patients prescribed cannabis-based medicines for chronic pain – a survey of pain medicine physicians in Canada, Germany and Israel.
A major concern with cannabis-based medicines and medical cannabis (CbM) is the risk of abuse and dependence. The face validity of the International Classification of Diseases (ICD-10) criteria for cannabis dependence in patients prescribed CbM for chronic pain has not been assessed.
